Tosco, L
Laenen, A
Briganti, A
Gontero, P
Karnes, R J
Albersen, M
Bastian, P J
Chlosta, P
Claessens, F
Chun, F K
Everaerts, W
Gratzke, C
Graefen, M
Kneitz, B
Marchioro, G
Salas, R S
Tombal, B
Van den Broeck, T
Moris, L
Battaglia, A
van der Poel, H
Walz, J
Bossi, A
De Meerleer, G
Haustermans, K
Van Poppel, H
Spahn, M
Joniau, S
,
Article History
Received: 5 February 2017
Revised: 7 April 2017
Accepted: 8 April 2017
First Online: 9 May 2017
Competing interests
: LT: research grants from Bayer, Ipsen, Ferring, Janssen; consulting or advisory role for Ipsen; travel, accommodation, expenses from Astellas, Bayer and Pierre-Fabre. SJ: company consultant for Astellas, Ipsen, Bayer, Sanofi and Janssen; has received company speaker honoraria from Astellas, Amgen, Bayer, Sanofi, Janssen and Ipsen; has participated in trials for Astellas, Janssen and Bayer; has received fellowship and travel grants from Astellas, Amgen, Bayer, Sanofi, Janssen, Ipsen and Pfizer; and has received grant and research support from Astellas, Bayer and Janssen. MA: travel, accommodation, expenses from Astellas, Amgen and Bayer. WE: travel, accommodation, expenses from Astellas. RJK: research funding from GenomeDX; patents, royalties, other intellectual property from GenomeDX. PG: honoraria from Janssen, Ipsen; Speaker’s Bureau from Medacs; research funding from Astellas; travel, accommodation, expenses from Janssen. TVdB: travel, accommodation, expenses from Ipsen. FKC: consulting or advisory role from Astellas, UroTech. HVDP: honoraria from Intuitive Surgical; consulting or advisory role from Astellas; research funding from Astellas, Storz; travel, accommodation, expenses from Intuitive Surgical, Storz. BT: honoraria from Amgen, Astellas, Bayer, Ferring, Sanofi and Janssen; consulting or advisory role—Astellas, Bayer, Ferring, Janssen, Takeda, Steba Biotech, Sanofi; Speaker’s Bureau—Amgen, Janssen; research funding—Ferring; travel, accommodation, expenses—Amgen, Astellas, Bayer, Ferring Janssen, Sanofi. GM: Speaker’s Bureau from Ipsen, Takeda; travel, accommodation, expenses from Ipsen, Takeda and Ferring. GDM: honoraria from Astellas, Ipsen, AstraZeneca, Bayer, Ferring, Sanofi, Janssen; consulting or advisory role—Astellas, Bayer, Ferring, Janssen, Ipsen, Sanofi; research funding—Ipsen; travel, accommodation, expenses—all of the above. AB: honoraria from Astellas, Ipsen, Ferring; consulting or advisor role from Janssen; Speaker’s Bureau from Ipsen, Ferring and Janssen; travel, accommodation, expenses from Ipsen. Remaining authors declare no conflict of interest.